Peri-Implantitis Treatment Market Size & Share, by Type {Surgical (Bone Regeneration, Open Flap Debridement, Implantoplasty), Non-Surgical (Mechanical Debridement, Laser Debridement, Antibiotics), Surface Decontamination (Chemical, Laser)}; End-user (Dental Clinics, Hospitals, Pharmacies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3922
  • Published Date: Mar 13, 2023
  • Report Format: PDF, PPT

Companies Dominating the Peri-Implantitis Treatment Landscape

    • Aetna Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Pfizer Inc.
    • Cadila Pharmaceuticals Limited
    • R N Laboratories Pvt Ltd
    • Neoss Limited
    • Basic Pharma Lifesciences Pvt Ltd
    • Dawood and Tanner
    • Prachi Pharmaceuticals Private Limited
    • Geistlich Pharma AG.
    • Healthy Life Pharma Private Limited.

Browse Key Market Insights with Data Illustration:


In The News

  • Neoss Limited announced the acquisition of Legend Life Tech, to establish Neoss China, a regional subsidiary of the global implant manufacturing company. Neoss Limited aims to expand its global presence in the Asia Pacific region.

  • Geistlich Pharma AG. acquired Meta Technologies S.r.l., along with the employees working for the company. Geistlich Pharma expanded its existing offering of oral regeneration specialists, with the acquisition of Meta Technologies S.r.l.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 3922
  • Published Date: Mar 13, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing consumption of cigarettes and increasing awareness of oral care are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2023-2035.

Lack of awareness regarding the disease and higher cost associated with peri-implantitis treatment is estimated to be the growth hindering factors for the market expansion.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Pfizer Inc., Cadila Pharmaceuticals Limited, R N Laboratories Pvt Ltd, Neoss Limited, Basic Pharma Lifesciences Pvt Ltd, Dawood and Tanner, Prachi Pharmaceuticals Private Limited, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, end-user, and by region.

The surgical segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying